Ownership

Jonathan Allan - GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: General Counsel & Corp Sec
Stock Symbol: STOK on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Jonathan Allan - trading volume in the past year for Stoke Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-39.4K	100%	$13.22	-$521K
Net	-39.4K	-100%		-$521K

Holdings reported by Jonathan Allan for Stoke Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Restricted Stock Units	24K	$379K	$15.78	Mar 27, 2024	Direct	Common Stock
Common Stock	21.5K	$279K	$12.99	Dec 9, 2024	Direct
Restricted Stock Unit (RSU)	12.4K	$149K	$12.07	Dec 1, 2024	Direct	Common Stock
Performance Stock Units	6K	$72.4K	$12.07	Dec 3, 2024	Direct	Common Stock
Stock Option (Right to Buy)	25.8K			May 20, 2024	Direct	Common Stock

Transactions reported by Jonathan Allan for Stoke Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.